The mission of Princeton University will be brought to life in a new way through Engage 2020, the inaugural innovation and entrepreneurship conference scheduled for November 4-6, 2020. Presented by the Princeton innovation and entrepreneurship team and its campus partners, Engage 2020 will offer more than 50 live, online sessions of relevance to academia, business and industry, Princeton alumni, entrepreneurs, investors, foundations and the intellectually curious.
- Wednesday, Oct 14, 2020
- Friday, Jul 31, 2020
A new relationship between the Princeton Catalysis Initiative (PCI) and Genentech, a biotechnology company based in South San Francisco, is enabling several Princeton faculty members to pursue mission-driven collaborations in fundamental research.
Genentech will fund five new projects, raising PCI’s total funded commitments to over $65M in just over two years.
- Thursday, Jun 25, 2020
Using radar commonly deployed to track speeders and fastballs, researchers have developed an automated system that will allow cars to peer around corners and spot oncoming traffic and pedestrians.
- Tuesday, Jun 23, 2020
The C3.ai Digital Transformation Institute has awarded $5.4 million to 26 projects to accelerate artificial intelligence research to mitigate COVID-19 and future pandemics. Princeton faculty members Matthew Desmond, Simon Levin, Stefana Parascho, H. Vincent Poor, Corina Tarnita and Mengdi Wang are among researchers to receive funding for their projects.
- Monday, Jun 15, 2020
The McGraw Center for Teaching and Learning(link is external) has awarded Hakan Türeci support from Princeton’s 250th Anniversary Fund for Innovation in Undergraduate Education, funding the overhaul of a senior-level quantum engineering course.
- Tuesday, May 5, 2020
In just six weeks, from March 19 to May 1, an international team of physicists and engineers led by Princeton’s Cristian Galbiati brought a ventilator from concept to FDA approval.
The U.S. Food and Drug Administration announced on Sunday, May 3, that the Mechanical Ventilator Milano (MVM) is safe for use in the United States under the FDA’s Emergency Use Authorization, which helps support public health during a crisis.
- Wednesday, Apr 22, 2020
'Open Facebook or Twitter on any given day during the Covid-19 global pandemic, and it takes just moments before a questionable claim about the coronavirus appears — 5G technology causes people to succumb to the virus; inhaling steam will cure it; the virus is a bioweapon gone wrong. From the origins of the virus or potential treatments to what the U.S. federal government is or is not doing in response, misinformation abounds.
- Thursday, Apr 16, 2020
by Catherine Zandonella, Office of the Dean for Research
- Tuesday, Feb 25, 2020
- Wednesday, Feb 12, 2020
Optimeos Life Sciences, a startup founded by two Princeton University faculty members, has reached agreements with six pharmaceutical companies to develop therapeutics using a Princeton-developed drug delivery technology. The collaborations have the potential to improve the effectiveness of medications for the treatment of diseases, ranging from cancer to diabetes.